Background illustration for clinical trials search

Paid Clinical Trials Richardson

Discover 1,933 paid clinical trials in Richardson, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

for
Pulmonary Disease, Chronic Obstructive
Location: Dallas TX, McKinney TX, Corsicana TX, Houston TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 40 - 70+

Code: NCT06959095

Phase 3, Recruiting

MDR - PMCF Study for Taperloc Complete Stems

for
Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries,
Location: Plano TX
Sponsor: Zimmer Biomet

Sex: All

Age: 18+

Code: NCT04028687

Recruiting

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

for
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD
Location: Plano TX, Milwaukee WI, Columbus OH, Washington D.C. DC,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT05966467

Recruiting

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

for
Non-small Cell Lung Cancer (NSCLC)
Location: Plano TX, Denton TX, Austin TX, Memphis TN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07291037

Phase 3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Allen TX, Plano TX, Carrollton TX, Dallas TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Plano TX, Dallas TX, Mesquite TX, McKinney TX,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Plano TX, Dallas TX, Austin TX, Houston TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Plano TX, Dallas TX, Cordova TN, Kansas City KS,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

for
Multiple Sclerosis
Location: Plano TX, Dallas TX, Oklahoma City OK, St Louis MO,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 18 - 55

Code: NCT06735248

Phase 2, Recruiting

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

for
Migraine
Location: Dallas TX, Frisco TX, Tomball TX, Houston TX,
Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT05156398

Phase 3, Recruiting

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

for
Relapsing Multiple Sclerosis
Location: Plano TX, Dallas TX, Fort Worth TX, Austin TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 40 - 70

Code: NCT06846281

Phase 3, Recruiting

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for
Metastatic HER2-positive Breast Cancer
Location: Irving TX, Fort Worth TX, Houston TX, Kansas City MO,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06435429

Phase 3, Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for
Systemic Lupus Erythematosus
Location: Mesquite TX, Frisco TX, Grapevine TX, Mansfield TX,
Sponsor: UCB Biopharma SRL

Sex: All

Age: 16+

Code: NCT06617325

Phase 3, Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

for
Refractory Rheumatoid Arthritis (RA),
Location: Mesquite TX, Irving TX, Arlington TX, Red Oak TX,
Sponsor: Artiva Biotherapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06991114

Phase 2, Recruiting

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout

for
Uncontrolled Gout
Location: Dallas TX, Lewisville TX, Round Rock TX,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07388498

Phase 3, Recruiting

ConsideRAte Study - Splenic Stimulation for RA

for
Rheumatoid Arthritis
Location: Mesquite TX, Allen TX, Austin TX, Altoona PA,
Sponsor: Galvani Bioelectronics

Sex: All

Age: 22 - 70+

Code: NCT05003310

Recruiting

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

for
Psoriatic Arthritis
Location: Mesquite TX, The Woodlands TX, Houston TX, Baytown TX,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07286058

Phase 3, Recruiting

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities

for
Periprosthetic Joint Infections
Location: Carrollton TX, San Antonio TX, Indianapolis IN,
Sponsor: Elute, Inc.

Sex: All

Age: 22+

Code: NCT05361941

Recruiting

Home With TablO outcoMEs (HOME) Registry

for
End Stage Renal Disease
Location: Plano TX, Lincoln NE, Helena MT, New York NY,
Sponsor: Outset Medical

Sex: All

Age: 15+

Code: NCT04526301

Recruiting

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Carrollton TX, Tyler TX, Oklahoma City OK,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07499232

Phase 3, Recruiting